First dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and cerebral venous sinus thrombosis: A pooled self-controlled case series study of 11.6 million individuals in England, Scotland, and Wales

BACKGROUND: Several countries restricted the administration of ChAdOx1 to older age groups in 2021 over safety concerns following case reports and observed versus expected analyses suggesting a possible association with cerebral venous sinus thrombosis (CVST). Large datasets are required to precisel...

Descripción completa

Detalles Bibliográficos
Autores principales: Kerr, Steven, Joy, Mark, Torabi, Fatemeh, Bedston, Stuart, Akbari, Ashley, Agrawal, Utkarsh, Beggs, Jillian, Bradley, Declan, Chuter, Antony, Docherty, Annemarie B., Ford, David, Hobbs, Richard, Katikireddi, Srinivasa Vittal, Lowthian, Emily, de Lusignan, Simon, Lyons, Ronan, Marple, James, McCowan, Colin, McGagh, Dylan, McMenamin, Jim, Moore, Emily, Murray, Josephine-L. K., Owen, Rhiannon K., Pan, Jiafeng, Ritchie, Lewis, Shah, Syed Ahmar, Shi, Ting, Stock, Sarah, Tsang, Ruby S. M., Vasileiou, Eleftheria, Woolhouse, Mark, Simpson, Colin R., Robertson, Chris, Sheikh, Aziz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863261/
https://www.ncbi.nlm.nih.gov/pubmed/35192598
http://dx.doi.org/10.1371/journal.pmed.1003927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863261/
https://www.ncbi.nlm.nih.gov/pubmed/35192598
http://dx.doi.org/10.1371/journal.pmed.1003927

Ejemplares similares